欧盟 - 丹麦文 - EMA (European Medicines Agency)

bial portela & companhia s.a. - opicapone - parkinsons sygdom - anti-parkinson-lægemidler - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

欧盟 - 丹麦文 - EMA (European Medicines Agency)

vericel denmark aps - autologe dyrkede chondrocytter - frakturer, brusk - andre midler mod forstyrrelser i muskel-skeletsystemet - reparation af knogles symptomatiske bruskfejl.

丹麦 - 丹麦文 - SEGES Landbrug & Fødevarer

bayer a/s - amidosulfuron, mefenpyr-diethyl, mefenpyr, iodosulfuron-methyl-na, iodosulfuron - pulver - 125 g/kg amidosulfuron ; 125 g/kg mefenpyr-diethyl ; (~ 106 g/kg mefenpyr ; 12,5 g/kg iodosulfuron-methyl-na ; (~ 11,6 g/kg iodosulfuron

欧盟 - 丹麦文 - EMA (European Medicines Agency)

medac gesellschaft für klinische spezialpräparate mbh - arsen trioxid - leukæmi, promyelocytisk, akut - antineoplastiske midler - arsenic trioxide medac is indicated for induction of remission, and consolidation in adult patients with:newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10 x 10³/μl) in combination with all-trans-retinoic acid (atra)relapsed/refractory apl (previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the pro-myelocytic leukaemia/retinoic-acid-receptor-alpha (pml/rarα) gene. svarprocenten af anden akut myeloid leukæmi undertyper til arsen trioxid har ikke været undersøgt.

欧盟 - 丹麦文 - EMA (European Medicines Agency)

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - andre narkotika stoffer - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

欧盟 - 丹麦文 - EMA (European Medicines Agency)

idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - søvninitierings- og vedligeholdelsesforstyrrelser - psykoleptika - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.

欧盟 - 丹麦文 - EMA (European Medicines Agency)

rad neurim pharmaceuticals eec sarl - melatonin - søvninitierings- og vedligeholdelsesforstyrrelser - psykoleptika - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.

丹麦 - 丹麦文 - SEGES Landbrug & Fødevarer

bayer a/s - propoxycarbazon-na, propoxycarbazon - vandopløseligt granulat - 700 g/kg propoxycarbazone-na; (~ 663 g/kg propoxycarbazon

丹麦 - 丹麦文 - SEGES Landbrug & Fødevarer

dow agrosciences danmark a/s - florasulam, aminopyralid - vanddispergerbart granulat - 150 g/kg florasulam ; 300 g/kg aminopyralid

丹麦 - 丹麦文 - SEGES Landbrug & Fødevarer

bayer a/s - thiacloprid - od-formulering - 240 g/l thiacloprid